Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

First-in-class PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363 in Patients with Advanced Colorectal Cancer: Safety and Efficacy Results from a Phase I Study.

Xueli Bai, Qin Xu,Xinjun Liang,Qian Chu,Xiaochen Zhang,Yiwen Chen,Nong Xu,Weijia Fang,Jianzhen Shan,Weiqin Jiang,Jianya Zhou,Yu-Long Zheng, Sixiang Long,Haonan Chen, Li Zhao,Hongli Wang,Jiya Sun,Xing Sun,Hui Zhou,Tingbo Liang

Journal of Clinical Oncology（2024）

Cited 0|Views33
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined